Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Eluting combination drugs from stents
Rajesh Thipparaboina
, Wahid Khan
, Abraham J. Domb
National Institute of Pharmaceutical Education and Research, Hyderabad
Hebrew University of Jerusalem
Research output
:
Contribution to journal
›
Short survey
›
peer-review
31
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Eluting combination drugs from stents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Stent
100%
Drug Combination
100%
Drug-eluting Stent
100%
Coronary Artery Disease
33%
Balloon Angioplasty
33%
Healing
16%
Cardiovascular Disease
16%
Cause of Death
16%
Gene Therapy
16%
Drug Development
16%
Restenosis
16%
Multiple Drugs
16%
Percutaneous Coronary Intervention
16%
Safe Drugs
16%
Effective Compounds
16%
Therapeutic Strategies
16%
Stent Thrombosis
16%
Surface Gene
16%
Elastic Recoil
16%
Laceration
16%
Re-epithelialization
16%
Coronary Artery
16%
Biodegradable Polymers
16%
In-stent Restenosis
16%
Bare Metal Stent
16%
Stent Development
16%
Nanoscale Surface Modification
16%
Dual Drug-eluting Stent
16%
VSMC Proliferation
16%
Intimal Hyperplasia
16%
Pro-healing
16%
Healing Agent
16%
Bioresorbable
16%
Polymer Therapeutics
16%
Polymer-based
16%
Promising Therapeutics
16%
Stenting Procedures
16%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
100%
Combination Drug
100%
Stent Thrombosis
50%
Prevalence
50%
Laceration
50%
In-Stent Restenosis
50%
Hyperplasia
50%
Restenosis
50%
Cardiovascular Disease
50%
Pathogenesis
50%
Medicine and Dentistry
Drug-Eluting Stent
100%
Combination Drug
100%
Coronary Artery Disease
28%
Percutaneous Transluminal Angioplasty
28%
Cardiovascular Disease
14%
Prevalence
14%
Restenosis
14%
Percutaneous Coronary Intervention
14%
Coronary Artery
14%
Stent Thrombosis
14%
Gene Therapy
14%
Stenting
14%
Laceration
14%
Neointimal Hyperplasia
14%
In-Stent Restenosis
14%
Elastic Recoil
14%
Pathogenesis
14%